Locoregional disease control after external beam radiotherapy in 91 patients with differentiated thyroid carcinoma and pT4 tumor stage - a single institution experience.

Not surprisingly, only a weak benefit of EBRT regarding local control was observed that did not reach statistical significance. 13 Gross, the unresectable residual disease is accepted as an indication for adjuvant radiotherapy in the 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. 23 Schwartz et al . reported that a total of 15 patients rece

also in 111,027 other papers